Fabino Life Sciences Past Earnings Performance
Past criteria checks 3/6
Fabino Life Sciences has been growing earnings at an average annual rate of 13.8%, while the Pharmaceuticals industry saw earnings growing at 17.2% annually. Revenues have been growing at an average rate of 32.5% per year. Fabino Life Sciences's return on equity is 0.9%, and it has net margins of 0.2%.
Key information
13.8%
Earnings growth rate
-24.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | 32.5% |
| Return on equity | 0.9% |
| Net Margin | 0.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fabino Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 211 | 0 | 2 | 0 |
| 31 Dec 23 | 181 | 1 | 3 | 0 |
| 30 Sep 23 | 152 | 1 | 4 | 0 |
| 30 Jun 23 | 93 | 1 | 4 | 0 |
| 31 Mar 23 | 34 | 0 | 4 | 0 |
| 31 Dec 22 | 33 | 1 | 4 | 0 |
| 30 Sep 22 | 32 | 1 | 5 | 0 |
| 30 Jun 22 | 36 | 0 | 5 | 0 |
| 31 Mar 22 | 42 | 0 | 5 | 0 |
| 31 Mar 21 | 31 | 0 | 3 | 0 |
| 31 Mar 20 | 75 | 1 | 2 | 0 |
| 31 Mar 19 | 28 | 0 | 3 | 0 |
Quality Earnings: 543444 has a high level of non-cash earnings.
Growing Profit Margin: 543444's current net profit margins (0.2%) are lower than last year (0.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543444's earnings have grown by 13.8% per year over the past 5 years.
Accelerating Growth: 543444's earnings growth over the past year (231.5%) exceeds its 5-year average (13.8% per year).
Earnings vs Industry: 543444 earnings growth over the past year (231.5%) exceeded the Pharmaceuticals industry 18.2%.
Return on Equity
High ROE: 543444's Return on Equity (0.9%) is considered low.